The prognostic value of response to the first cycle of chemotherapy in small cell lung cancer. Results of a multicenter German trial.

[1]  O. Dalesio,et al.  Combination chemotherapy with adriamycin, etoposide, and cyclophosphamide for small cell carcinoma of the lung. A study by the EORTC lung cancer working party (Belgium) , 1985, Cancer.

[2]  T. Pajak,et al.  Combined modality therapy with radiotherapy, chemotherapy, and immunotherapy in limited small-cell carcinoma of the lung: a Phase III cancer and Leukemia Group B Study. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  H. Muss,et al.  VP-16-213 in combination chemotherapy with chest irradiation for small-cell lung cancer: a randomized trial of the Piedmont Oncology Association. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  D. Gandara,et al.  Chemotherapy of small-cell carcinoma of lung: a randomized comparison of alternating and sequential combination chemotherapy programs. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  H. Cohen,et al.  Randomized trial of radiotherapy to the thorax in limited small-cell carcinoma of the lung treated with multiagent chemotherapy and elective brain irradiation: a preliminary report. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  R. Livingston,et al.  Combined modality treatment of extensive small cell lung cancer: a Southwest Oncology Group study. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  J. Herman,et al.  Combined modality induction therapy without maintenance chemotherapy for small cell carcinoma of the lung. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  F. Hirsch,et al.  Continuous versus alternating combination chemotherapy for advanced small cell carcinoma of the lung. , 1983, Cancer research.

[9]  J. Klastersky,et al.  Cisplatin, adriamycin, and etoposide (cav) for remission induction of small‐cell bronchogenic carcinoma. Evaluation of efficacy and toxicity and pilot study of a “late intensification” with autologous bone‐marrow rescue , 1982, Cancer.

[10]  D. Dalley,et al.  Alternating non‐cross‐resistant combination chemotherapy for small cell anaplastic carcinoma of the lung , 1982, Cancer.

[11]  C. Coltman,et al.  Combination chemotherapy, radiotherapy, and BCG immunotherapy in limited small‐cell carcinoma of the lung: A Southwest Oncology group study , 1982, Cancer.

[12]  D. V. Van Echo,et al.  Combination chemotherapy for small cell carcinoma of the lung: continuous versus alternating non-cross-resistant combinations. , 1982, Cancer treatment reports.

[13]  T. Fleming,et al.  Evaluation of response criteria in advanced lung cancer , 1979, Cancer.

[14]  J. Hokanson,et al.  Comparing survival of responders and nonresponders after treatment: a potential source of confusion in interpreting cancer clinical trials. , 1983, Controlled clinical trials.

[15]  H. Hansen,et al.  Role of chemotherapy in small cell lung cancer: a consensus report of the International Association for the Study of Lung Cancer workshop. , 1983, Cancer treatment reports.